RS174536 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:None]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Phosphatidylcholine (O-18:0_20:4) levels | C | OR: 0.31 | 2E-72 | PubMed |
| Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid) | A | β: 0.02 | 1E-63 | PubMed |
| Phosphatidylcholine (O-18:1_20:4) levels | C | OR: 0.28 | 4E-63 | PubMed |
| Phosphatidylcholine diacyl C36:5 levels | A | OR: 0.13 | 5E-59 | PubMed |
| Phosphatidylcholine acyl-alkyl C42:5 levels | A | OR: 14.99 | 8E-51 | PubMed |
| Phosphatidylethanolamine (O-18:1_20:4) levels | C | OR: 0.25 | 1E-49 | PubMed |
| Phosphatidylcholine (O-18:0_20:4) levels | C | OR: 0.32 | 1E-46 | PubMed |
| Arachidonoylcholine levels | C | OR: 0.23 | 2E-44 | PubMed |
| Sex hormone-binding globulin levels adjusted for BMI and heel estimated bone mineral density | — | — | 3E-42 | PubMed |
| Phosphatidylcholine (O-18:1_20:4) levels | C | OR: 0.29 | 5E-39 | PubMed |
| Metabolite levels (1-myristoyl-2-arachidonoyl-GPC (14:0/20:4); C34:4 PC; C34_4_PC) | C | OR: 0.28 | 5E-36 | PubMed |
| Metabolic dysfunction-associated steatotic liver disease (MTAG) | A | β: 0.053 | 1E-35 | PubMed |
| Phosphatidylethanolamine (O-18:1_20:4) levels | C | OR: 0.27 | 8E-34 | PubMed |
| Resting heart rate | C | OR: 0.4 | 2E-30 | PubMed |
| Phosphatidylcholine diacyl C42:6 levels | A | OR: 11.34 | 9E-30 | PubMed |
| Phosphatidylcholine diacyl C42:1 levels | A | OR: 10.9 | 1E-27 | PubMed |
| Saturated fatty acids levels | C | — | 1E-25 | PubMed |
| Sphingomyeline C16:1 levels | A | OR: 10.38 | 3E-25 | PubMed |
| Phosphatidylethanolamine (O-16:1_20:4) levels | C | OR: 0.21 | 2E-21 | PubMed |
| Phosphatidylcholine (18:0_22:5) levels | C | OR: 0.27 | 3E-21 | PubMed |